PharmExec

Roundup: Capital Flows into Pharma with Funding Rounds and Loan Facilities

Biotech funding surges as companies like Pelage, Kardigan, and Kailera secure millions to innovate treatments for hair loss, ...

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Webinar on December 11 to feature leading KOLs in dermatology and hair loss alongside Absci leadershipPhase 1/2a trial now expected to begin in ...

This Nurse Was Diagnosed with the 'Sneaky' Kind of Breast Cancer Not Many Know About: 'Sharing My Story Is the Best Kind of Nursing I Can Do'

Tammy McDevitt didn't know what lobular cancer was until she got her diagnosis; now with treatment behind her, she shares ...

‘Love Jones’ Alums Nia Long & Larenz Tate Reteaming On Netflix Romantic Drama From ‘Sylvie’s Love’s Eugene Ashe

Love Jones' stars Nia Long & Larenz Tate are reteaming on a romantic drama that has been greenlighted by Netflix with Eugene ...
Cantech Letter

Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient’s own) stem cell therapy company offering VesCell™ ...

Next-Generation Targeted Therapies Reshape Precision Oncology Landscape

Biomarker-driven drug development is accelerating across oncology as companies advance novel mechanisms targeting previously ...
The Malaysian Reserve

Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region

Strengthens Viatris' Presence in Japan With the Addition of Two Innovative Assets Targeting Areas of Significant Unmet Medical Need Leverages Existing ...